✦ LIBER ✦

Dual Protease Inhibitor Therapy in HIV-Infected Patients: Pharmacologic Rationale and Clinical Benefits

✍ Scribed by Flexner, Charles

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Protease inhibitor resistance in HIV-inf

✍ Jorge L. Martinez-Cajas; Mark A. Wainberg 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 515 KB

Weight gain associated with protease inh

✍ R.B. Stricker; B. Goldberg 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 328 KB

Relapsing Visceral Leishmaniasis in HIV-

✍ J. L. Casado; R. Lopez-Velez; V. Pintado; C. Quereda; A. Antela; S. Moreno 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 60 KB

Frequency of oropharyngeal candidiasis i

✍ P.Diz Dios; A. Ocampo; C. Miralles; I. Otero; I. Iglesias; N. Rayo 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Lack of benefit or protease inhibitors o

✍ Javier García-Samaniego; Rosa Bravo; Jesús Castilla; María Gómez-Cano; Fernando 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Protease inhibitor therapy slightly impr

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB